156 related articles for article (PubMed ID: 24189269)
1. Characterization of subpopulation lacking both B-cell and plasma cell markers in Waldenstrom macroglobulinemia cell line.
Wada N; Zhan M; Hori Y; Honma K; Ikeda J; Morii E
Lab Invest; 2014 Jan; 94(1):79-88. PubMed ID: 24189269
[TBL] [Abstract][Full Text] [Related]
2. Requirement of CXCL12-CXCR7 signaling for CD20(-) CD138(-) double-negative population in lymphoplasmacytic lymphoma.
Wada N; Ikeda J; Nojima S; Tahara S; Ohshima K; Okuzaki D; Morii E
Lab Invest; 2016 May; 96(5):517-25. PubMed ID: 26878134
[TBL] [Abstract][Full Text] [Related]
3. [Lymphoplasmacytic lymphoma with Waldenström's macroglobulinemia: a clinicopathological and immunophenotypic study of 40 Chinese patients].
Liang DN; Li GD; Dai L; Huang J; Wang WY; Feng WH; Li FY; Liao DY
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):728-32. PubMed ID: 20079010
[TBL] [Abstract][Full Text] [Related]
4. Clinical, Laboratory, and Bone Marrow Findings of 31 Patients With Waldenström Macroglobulinemia.
Ahn A; Park CJ; Cho YU; Jang S; Seo EJ; Lee JH; Yoon DH; Suh C
Ann Lab Med; 2020 May; 40(3):193-200. PubMed ID: 31858758
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1.
Hodge LS; Novak AJ; Grote DM; Braggio E; Ketterling RP; Manske MK; Price Troska TL; Ziesmer SC; Fonseca R; Witzig TE; Morice WG; Gertz MA; Ansell SM
Blood; 2011 May; 117(19):e190-7. PubMed ID: 21415268
[TBL] [Abstract][Full Text] [Related]
6. Effect of plasma-activated medium on the decrease of tumorigenic population in lymphoma.
Wada N; Ikeda JI; Tanaka H; Sakakita H; Hori M; Ikehara Y; Morii E
Pathol Res Pract; 2017 Jul; 213(7):773-777. PubMed ID: 28554762
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotyping of Waldenströms macroglobulinemia cell lines reveals distinct patterns of surface antigen expression: potential biological and therapeutic implications.
Paulus A; Chitta KS; Wallace PK; Advani PP; Akhtar S; Kuranz-Blake M; Ailawadhi S; Chanan-Khan AA
PLoS One; 2015; 10(4):e0122338. PubMed ID: 25853860
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic features of lymphoplasmacytic lymphoma].
Liu EB; Zhang PH; Li ZQ; Sun Q; Yang QY; Fang LH; Sun FJ; Qiu LG
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):308-12. PubMed ID: 20654153
[TBL] [Abstract][Full Text] [Related]
9. Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia.
Roberts MJ; Chadburn A; Ma S; Hyjek E; Peterson LC
Am J Clin Pathol; 2013 Feb; 139(2):210-9. PubMed ID: 23355206
[TBL] [Abstract][Full Text] [Related]
10. CD138 expression helps distinguishing Waldenström's macroglobulinemia (WM) from splenic marginal zone lymphoma (SMZL).
Kyrtsonis MC; Levidou G; Korkolopoulou P; Koulieris E; Bartzi V; Maltezas D; Pangalis GA; Kalpadakis C; Dimou M; Georgiou G; Vassilakopoulos TP; Angelopoulou MK; Salpeas V; Tsaftaridis P; Patsouris E; Panayiotidis P; Tzenou TK
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):99-102. PubMed ID: 21454203
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometry detection of CD138 expression continuum between monotypic B and plasma cells is associated with both high IgM peak levels and MYD88 mutation and contributes to diagnosis of Waldenström macroglobulinemia.
Gayet M; Leymarie V; Derouault P; Guérin E; Vaidié J; Pascal V; Boulin M; Dmytruk N; Chauzeix J; Trimoreau F; Gachard N; Feuillard J; Rizzo D
Cytometry B Clin Cytom; 2022 Jan; 102(1):62-69. PubMed ID: 33634586
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer.
Lundgren S; Berntsson J; Nodin B; Micke P; Jirström K
J Ovarian Res; 2016 Apr; 9():21. PubMed ID: 27048364
[TBL] [Abstract][Full Text] [Related]
13. Differential protein expression profile between CD20 positive and negative cells of the NCI-H929 cell line.
Geng CY; Liu N; Yang GZ; Liu AJ; Leng Y; Wang HJ; Li LH; Wu Y; Li YC; Chen WM
Asian Pac J Cancer Prev; 2012; 13(11):5409-13. PubMed ID: 23317192
[TBL] [Abstract][Full Text] [Related]
14. Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy.
Treon SP; Shima Y; Preffer FI; Doss DS; Ellman L; Schlossman RL; Grossbard ML; Belch AR; Pilarski LM; Anderson KC
Semin Oncol; 1999 Oct; 26(5 Suppl 14):97-106. PubMed ID: 10561024
[TBL] [Abstract][Full Text] [Related]
15. Characterization of clonogenic multiple myeloma cells.
Matsui W; Huff CA; Wang Q; Malehorn MT; Barber J; Tanhehco Y; Smith BD; Civin CI; Jones RJ
Blood; 2004 Mar; 103(6):2332-6. PubMed ID: 14630803
[TBL] [Abstract][Full Text] [Related]
16. Transformation to diffuse large B-cell lymphoma with germinal center B-cell like subtype and discordant light chain expression in a patient with Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
Kobayashi H; Asada N; Egusa Y; Ikeda T; Sakamoto M; Abe M; Ennishi D; Sakata M; Takaki A; Kawahara S; Meguri Y; Nishimori H; Fujii N; Matsuoka KI; Sato Y; Yoshino T; Maeda Y
Int J Hematol; 2021 Sep; 114(3):401-407. PubMed ID: 33907976
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells.
Kawano Y; Kikukawa Y; Fujiwara S; Wada N; Okuno Y; Mitsuya H; Hata H
Int J Oncol; 2013 Dec; 43(6):1809-16. PubMed ID: 24126540
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer.
Berntsson J; Nodin B; Eberhard J; Micke P; Jirström K
Int J Cancer; 2016 Sep; 139(5):1129-39. PubMed ID: 27074317
[TBL] [Abstract][Full Text] [Related]
19. [Nodal lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia: a clinicopathological and prognostical study].
Zhang DD; Hu PZ; Li P; Jiang GZ; Yin YH; Wang GN; Zhao WG; Zhang YP; Li WC
Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):592-597. PubMed ID: 34078045
[No Abstract] [Full Text] [Related]
20. Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines.
Paíno T; Sarasquete ME; Paiva B; Krzeminski P; San-Segundo L; Corchete LA; Redondo A; Garayoa M; García-Sanz R; Gutiérrez NC; Ocio EM; San-Miguel JF
PLoS One; 2014; 9(3):e92378. PubMed ID: 24658332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
